The global mobile cardiac telemetry systems market size is expected to reach USD 1.58 billion by 2027, registering a CAGR of 11.3% during the forecast period, according to a new report by Grand View Research, Inc. Increasing prevalence of cardiovascular disorder, need for effective arrhythmia management, and technological advancement in telemetry devices are driving the market growth.
Increasing
demand for real-time cardiac monitoring and self-care management are boosting
the demand for mobile cardiac telemetry devices. In addition, presence of
advanced healthcare infrastructure, high disposable income in the developed
countries is further propelling the revenue. Moreover, these devices found to
be helpful in monitoring COVID-19 patients taking azithromycin and hydroxychloroquine medication
which is expected to boost the market revenue. The market is technology driven
and the key industry players are continuously trying to develop user friendly
devices to sustain their market share.
In
April 2020, Medicomp, Inc. partnered with the Lenox Hill Hospital to monitor
heart's electrical conduction of COVID-19 patients with certain medication by
its TelePatch- Mobile Cardiac Telemetry (MCT), which is expected to increase
the adoption of this device in the forthcoming years
Full Research Report On Mobile Cardiac Telemetry Systems Market Visit Here:
https://www.grandviewresearch.com/industry-analysis/mobile-cardiac-telemetry-systems-market
Mobile Cardiac
Telemetry Systems Market Report Highlights
- In terms of revenue, lead
based dominated the application segment in 2019 owing to its accuracy and
ease of use. Moreover, the product is cost-effective as compared to
patch-based which is further propelling the demand
- Patch based segment is
expected to show lucrative growth over the forecast period. The growth can
be attributed to its increased adoption in outpatient facilities and
ambulatory centers
- On basis of end use,
hospitals held the largest revenue share in 2019 owing to increased number
of minimally invasive surgeries within these facilities
- The cardiac centers segment
is expected to witness the fastest growth over the forecast period owing
to its associated advantages such as reduced wait times, availability of
skilled professionals and shorter stay duration
Request a Sample Copy of the Report @
https://www.grandviewresearch.com/industry-analysis/mobile-cardiac-telemetry-systems-market/request/rs1
Mobile Cardiac
Telemetry Systems Market Segmentation
Grand View Research has segmented
the global mobile cardiac telemetry systems market on the basis of application,
end use, and region:
Mobile Cardiac
Telemetry Systems Application Outlook (Revenue, USD Million, 2016 - 2027)
- Lead-based
- Patch-based
Mobile Cardiac
Telemetry Systems End-use Outlook (Revenue, USD Million, 2016 - 2027)
- Hospitals
- Cardiac Centers
- Others
Mobile Cardiac
Telemetry Systems Regional Outlook (Revenue, USD Million, 2016 - 2027)
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Italy
- Spain
- Asia Pacific
- Japan
- China
- India
- Australia
- Latin America
- Brazil
- Mexico
- Middle East & Africa
- South Africa
- Saudi Arabia
List of Key Players
of Mobile Cardiac Telemetry System Market
- BioTelemetry, Inc.
- ScottCare
- Biotricity Inc
- Welch Allyn
- Applied Cardiac Systems Inc
- Medicomp Inc.
- Preventice Solutions
- Telerhythmics LLC
- Zoll Medical Corporation
- iRhythm Technologies, Inc.
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
For more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment